RecruitingNCT05871164

Longitudinal, Prospective, French, Multicenter Cohort Study on Pancreatic Radiofrequency


Sponsor

GCS Ramsay Santé pour l'Enseignement et la Recherche

Enrollment

200 participants

Start Date

Jun 12, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of the study is to evaluate the oncological efficacy of pancreatic radiofrequency by the objective response rate (complete and partial responses according to RECIST 1.1.), 5 years after the end of treatment.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This French study is collecting data on patients who receive radiofrequency ablation (a procedure that uses heat generated by radio waves to destroy tumour tissue) for pancreatic tumours, to understand how well it works and what the outcomes are over time. **You may be eligible if...** - You are 18 or older - You have a pancreatic tumour that has been recommended for treatment with ultrasound-guided radiofrequency ablation - This recommendation was made by a multidisciplinary medical team - You are able to understand the study information and attend follow-up visits **You may NOT be eligible if...** - You have a medical contraindication to radiofrequency treatment - You are pregnant or breastfeeding Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREPancreatic radiofrequency

Pancreatic radiofrequency is similar to a puncture under echoendoscopy. The lesion is located then punctured by transgastric or transduodenal route either using a 19 gauge needle with exchange of the stylet for a probe, or using a 19 gauge needle whose distal end of 5-10 mm corresponds to the active part, connected to a generator with an integrated cooling system.


Locations(1)

CHI Toulon La Seyne

Toulon, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05871164


Related Trials